Associated Papers
Detrimental effects of melanocortin-1 receptor (MC1R) variants on the clinical outcomes of BRAF V600 metastatic melanoma patients treated with BRAF inhibitors.
Guida M et al.
Pigment Cell & Melanoma Research, 2016
Select a paper to view details